Catalyst Pharmaceuticals: Angelini Deal Caps A Potentially Better Story
Catalyst Pharmaceuticals Inc CPRX
$31.26
▼ -0.06%
($-0.02)
Open
$31.28
Prev Close
$31.28
Day Range
$31.24 – $31.30
52W Range
$19.05 – $32.56
Market Cap
$3.83B
P/E (TTM)
17.29
Beta
0.75
EPS (TTM)
$1.74
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2006-11-08 |
| Shares Out. | 122,380,000 |
| Website | catalystpharma.com/ ↗ |
| Phone | 13055292522 |
Catalyst Pharmaceuticals Inc is a publicly traded company under the ticker symbol CPRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-05-01)
📰 Latest News for CPRX
UPDATE: Catalyst Pharmaceuticals Q1 Adj. EPS $0.79 Beats $0.46 Estimate, Sales $149.390M Beat $148.174M Estimate.
Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results
Catalyst Pharmaceuticals Q1 Sales $149.390M Beat $148.174M Estimate.
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Scores 7/10 Fundamental Rating in Affordable Growth Screen
Earnings Scheduled For May 11, 2026